AZILSARTAN AS A POTENT ANTIHYPERTENSIVE DRUG WITH POSSIBLE PLEIOTROPIC CARDIOMETABOLIC EFFECTS: A REVIEW STUDY.

Background: Hypertension related cardiovascular (CV) complications could be amplified by the presence of metabolic co-morbidities. Azilsartan medoxomil (AZL-M) is the eighth approved member of angiotensin II receptor blockers (ARBs), a drug class of high priority in the management of hypertensive su...

Full description

Bibliographic Details

Published in:	Frontiers in Pharmacology
Main Authors:	Georgiopoulos Georgios, Vasiliki Katsi, Dimitrios Oikonomou, Georgia Vamvakou, Evangelia Koutli, Aggeliki Laina, Constantinos Tsioufis, Petros Nihoyannopoulos, Dimitrios Tousoulis
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2016-08-01
Subjects:	Diabetes Mellitus Hypertension cardiovascular metabolic Azilsartan medoxomil Pleiotropic
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00235/full